Lungs & Breathing

Lungs & Breathing

This is a randomized, double-blind, parallel group, placebo-controlled study designed to evaluate the efficacy and safety of a fixed 300 mg dose of tralokinumab administered subcutaneously in subjects with uncontrolled asthma despite the use of regular asthma controller inhaled medication and having a history of asthma exacerbations.Approximately...